These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 24043708)

  • 1. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
    Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
    J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
    Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
    Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
    J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.
    Giovannetti A; Ensoli F; Mazzetta F; De Cristofaro M; Pierdominici M; Muratori DS; Fiorelli V; Aiuti F
    Clin Exp Immunol; 1999 Oct; 118(1):87-94. PubMed ID: 10540164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in CCR5 and CXCR4 expression and beta-chemokine production in HIV-1-infected patients treated with highly active antiretroviral therapy.
    Pierdominici M; Giovannetti A; Ensoli F; Mazzetta F; Marziali M; De Cristofaro MR; Santini-Muratori D; Leti W; Aiuti F
    J Acquir Immune Defic Syndr; 2002 Feb; 29(2):122-31. PubMed ID: 11832680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term antiretroviral therapy fails to reduce the expanded activated CCR5-expressing CD4+ T lymphocyte population or to restore the depleted naive population in chronically HIV-infected individuals with active pulmonary tuberculosis.
    Kabue JP; de Swardt D; de Beer C; Glashoff RH
    AIDS Res Hum Retroviruses; 2013 May; 29(5):769-77. PubMed ID: 23259904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals.
    Ostrowski MA; Justement SJ; Catanzaro A; Hallahan CA; Ehler LA; Mizell SB; Kumar PN; Mican JA; Chun TW; Fauci AS
    J Immunol; 1998 Sep; 161(6):3195-201. PubMed ID: 9743388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5.
    Rucker RP; Day NK; Good RA; Kamchaisatian W; Emmanuel P; Sleasman JW; Mayeski C; Dinglasan E; Haraguchi S; Tangsinmankong N
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):272-6. PubMed ID: 15478388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CC chemokine receptor 5 cell-surface expression in relation to CC chemokine receptor 5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM; Blaak H; Brouwer M; Schuitemaker H
    J Immunol; 1999 Oct; 163(8):4597-603. PubMed ID: 10510404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor and chemokine receptor expression in HIV-infected T lymphocyte subsets.
    Miller Sanders C; Cruse JM; Lewis RE
    Exp Mol Pathol; 2010 Feb; 88(1):26-31. PubMed ID: 19769961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does cyclosporin A affect CCR5 and CXCR4 expression in primary HIV-1-infected patients?
    Biswas P; Galli A; Galli L; Tassan Din C; Vecchi A; Malnati M; Lazzarin A; Tambussi G
    Cytometry B Clin Cytom; 2007 Nov; 72(6):433-41. PubMed ID: 17474134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy.
    Nicholson JK; Browning SW; Hengel RL; Lew E; Gallagher LE; Rimland D; McDougal JS
    J Acquir Immune Defic Syndr; 2001 Jun; 27(2):105-15. PubMed ID: 11404531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD20+ T cell numbers are decreased in untreated HIV-1 patients and recover after HAART.
    Förster F; Singla A; Arora SK; Schmidt RE; Jacobs R
    Immunol Lett; 2012 Aug; 146(1-2):74-8. PubMed ID: 22677201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.
    Bogner JR; Lutz B; Klein HG; Pollerer C; Troendle U; Goebel FD
    HIV Med; 2004 Jul; 5(4):264-72. PubMed ID: 15236615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The expression of some homing and co-receptor molecules on CD4+ T cells in AIDS patients].
    Tan Y; Zhang MX; Liu YX; Chen XC; Zhou BP; Wang H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):257-60. PubMed ID: 20108767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful HAART is associated with high B-chemokine levels in chronic HIV type 1-infected patients.
    Brito A; Almeida A; Gonsalez CR; Mendonça M; Ferreira F; Fernandes SS; Duarte AJ; Casseb J
    AIDS Res Hum Retroviruses; 2007 Jul; 23(7):906-12. PubMed ID: 17678475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy.
    Valentin A; Rosati M; Patenaude DJ; Hatzakis A; Kostrikis LG; Lazanas M; Wyvill KM; Yarchoan R; Pavlakis GN
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7015-20. PubMed ID: 12011460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.